HomeGeneticsConditionTranscobalamin deficiency
Back to Condition
Transcobalamin deficiency
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Condition

Transcobalamin deficiency

Transcobalamin deficiency is a rare genetic disorder that prevents the body from properly transporting vitamin B12 (cobalamin) to cells, leading to impaired growth, blood cell shortages, and neurological problems early in life.

Overview

Transcobalamin deficiency is a disorder that impairs the transport of cobalamin (also known as vitamin B12) within the body. Cobalamin is obtained from the diet; this vitamin is found in animal products such as meat, eggs, and shellfish. An inability to transport cobalamin within the body results in cells that lack cobalamin, which they need for many functions including cell growth and division (proliferation) and DNA production. The absence of cobalamin leads to impaired growth, a shortage of blood cells, and many other signs and symptoms that usually become apparent within the first weeks or months of life.

The prevalence of transcobalamin deficiency is unknown. At least 45 affected individuals have been described in the medical literature.

Symptoms

The first signs of transcobalamin deficiency are typically a failure to gain weight and grow at the expected rate (failure to thrive), vomiting, diarrhea, inflammation and open sores (ulcers) on the mucous membranes such as the lining inside the mouth. Neurological function is impaired in affected individuals, and they can experience progressive stiffness and weakness in their legs (paraparesis), muscle twitches (myoclonus), or intellectual disability.

People with transcobalamin deficiency often develop a blood disorder called megaloblastic anemia. Megaloblastic anemia results in a shortage of red blood cells, and the remaining red blood cells are abnormally large. Individuals with transcobalamin deficiency may also have a shortage of white blood cells (neutropenia), which can lead to reduced immune system function. Decreased cellular cobalamin can lead to a buildup of certain compounds in the body, resulting in metabolic conditions known as methylmalonic aciduria or homocystinuria.

Causes

Mutations in the TCN2 gene cause transcobalamin deficiency. The TCN2 gene provides instructions for making a protein called transcobalamin. This protein attaches (binds) to cobalamin and transports the vitamin to cells throughout the body. Within cells, cobalamin helps certain enzymes carry out chemical reactions. Cobalamin plays a role in the processes that produce the building blocks of DNA and break down various compounds such as fatty acids; these processes are needed for cell proliferation and the production of cellular energy.

Most TCN2 gene mutations that cause transcobalamin deficiency lead to a complete or near-complete lack (deficiency) of transcobalamin. Other TCN2 gene mutations result in a transcobalamin protein that cannot transport cobalamin to cells. The resulting lack of cobalamin within cells interferes with the functioning of certain enzymes, which impacts many cell activities. As a result, a wide range of signs and symptoms can develop including impaired growth, blood cell shortages, and neurological problems.

Inheritance

This condition is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.

Other Names

  • TC deficiency
  • TC II deficiency
  • TCN2 deficiency
  • Transcobalamin II deficiency

Frequently Asked Questions

The long-term prognosis is significantly better with early diagnosis and consistent treatment. If B12 injections are started promptly in infancy, many children can achieve normal growth and development, and prevent severe neurological damage. However, if treatment is delayed, there is a higher risk of irreversible neurological problems, intellectual disability, and other long-term complications. Lifelong adherence to treatment is essential.
Transcobalamin deficiency is treated with regular, lifelong injections of vitamin B12 (cobalamin). Early and consistent treatment is crucial. With proper treatment, many symptoms, such as the blood cell shortages (megaloblastic anemia, neutropenia) and gastrointestinal issues, can improve significantly. Neurological symptoms may also stabilize or improve, but some developmental delays or intellectual disability, especially if present before treatment, might persist.
The first signs typically appear within the first weeks or months of life and include a failure to gain weight and grow as expected (failure to thrive), frequent vomiting and diarrhea, and inflammation or open sores (ulcers) on mucous membranes, such as inside the mouth. Neurological symptoms like muscle twitches or progressive leg stiffness can also develop.
While vitamin B12 is obtained from animal products in the diet, individuals with transcobalamin deficiency cannot properly transport this vitamin to their cells, regardless of dietary intake. Therefore, dietary changes alone are not sufficient. The primary treatment is B12 injections, which bypass the transport issue. A balanced diet is still important for overall health, but it does not replace the need for medical B12 supplementation.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

Meyahealth

Ⓒ 2026. All rights reserved by MEYA